TrialLancet (London, England)2022

Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial.

Daniel J Jackson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.